Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Positron-Emission Tomography | 40 | 2024 | 6585 | 3.230 |
Why?
|
Granzymes | 5 | 2024 | 276 | 2.570 |
Why?
|
Molecular Imaging | 13 | 2023 | 819 | 2.290 |
Why?
|
Spectroscopy, Near-Infrared | 19 | 2012 | 739 | 1.910 |
Why?
|
Receptor, erbB-3 | 4 | 2024 | 142 | 1.790 |
Why?
|
Cryosurgery | 2 | 2024 | 474 | 1.280 |
Why?
|
Immunotherapy | 7 | 2024 | 4642 | 1.240 |
Why?
|
Fluorescent Dyes | 24 | 2020 | 1902 | 1.210 |
Why?
|
Mice, Nude | 31 | 2022 | 3604 | 1.200 |
Why?
|
Nuclear Medicine | 3 | 2015 | 257 | 1.170 |
Why?
|
Molecular Probe Techniques | 5 | 2010 | 111 | 1.160 |
Why?
|
Radiopharmaceuticals | 20 | 2022 | 2682 | 1.150 |
Why?
|
Cathepsin B | 9 | 2020 | 80 | 1.100 |
Why?
|
Colonic Neoplasms | 12 | 2018 | 2528 | 1.090 |
Why?
|
Spectrometry, Fluorescence | 10 | 2013 | 684 | 1.070 |
Why?
|
Medical Oncology | 5 | 2023 | 2316 | 1.060 |
Why?
|
Receptors, Somatostatin | 3 | 2018 | 137 | 1.010 |
Why?
|
Fluorine Radioisotopes | 3 | 2018 | 420 | 0.940 |
Why?
|
Mice | 107 | 2024 | 81324 | 0.920 |
Why?
|
Cell Line, Tumor | 33 | 2022 | 16947 | 0.910 |
Why?
|
Matrix Metalloproteinases | 4 | 2015 | 392 | 0.910 |
Why?
|
Glycolates | 1 | 2023 | 40 | 0.910 |
Why?
|
Neoplasms | 16 | 2023 | 22125 | 0.870 |
Why?
|
Fluorodeoxyglucose F18 | 14 | 2022 | 2025 | 0.820 |
Why?
|
Animals | 127 | 2024 | 168083 | 0.790 |
Why?
|
Cathepsins | 4 | 2008 | 241 | 0.780 |
Why?
|
Neoplasms, Experimental | 7 | 2016 | 1225 | 0.770 |
Why?
|
Ductus Arteriosus | 1 | 2021 | 42 | 0.750 |
Why?
|
Microscopy, Fluorescence | 13 | 2014 | 2637 | 0.750 |
Why?
|
Persistent Fetal Circulation Syndrome | 1 | 2021 | 80 | 0.730 |
Why?
|
Gallium Radioisotopes | 4 | 2023 | 195 | 0.710 |
Why?
|
Methionine | 2 | 2022 | 570 | 0.680 |
Why?
|
Molecular Targeted Therapy | 5 | 2018 | 2813 | 0.680 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2021 | 216 | 0.660 |
Why?
|
Colorectal Neoplasms | 10 | 2019 | 6919 | 0.650 |
Why?
|
Arthritis, Experimental | 7 | 2014 | 291 | 0.640 |
Why?
|
Disease Models, Animal | 30 | 2024 | 18217 | 0.630 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2021 | 2293 | 0.610 |
Why?
|
Genes, cdc | 1 | 2018 | 114 | 0.610 |
Why?
|
Octreotide | 3 | 2023 | 154 | 0.610 |
Why?
|
Catheterization | 4 | 2007 | 1428 | 0.600 |
Why?
|
Liver Neoplasms | 5 | 2021 | 4308 | 0.590 |
Why?
|
Adenocarcinoma | 14 | 2016 | 6340 | 0.580 |
Why?
|
Dihydrotestosterone | 1 | 2018 | 195 | 0.580 |
Why?
|
Sodium Fluoride | 1 | 2017 | 66 | 0.580 |
Why?
|
Endocarditis | 1 | 2021 | 349 | 0.560 |
Why?
|
Chest Pain | 1 | 2024 | 1095 | 0.550 |
Why?
|
Misonidazole | 2 | 2015 | 33 | 0.530 |
Why?
|
Spectrophotometry, Infrared | 2 | 2007 | 117 | 0.520 |
Why?
|
Organometallic Compounds | 2 | 2023 | 647 | 0.520 |
Why?
|
Esophageal Neoplasms | 4 | 2015 | 1658 | 0.520 |
Why?
|
Breast Neoplasms | 12 | 2024 | 20981 | 0.520 |
Why?
|
Antineoplastic Agents | 12 | 2021 | 13630 | 0.520 |
Why?
|
Neoplasm Transplantation | 14 | 2018 | 2010 | 0.510 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2018 | 550 | 0.510 |
Why?
|
Neuroendocrine Tumors | 3 | 2023 | 641 | 0.500 |
Why?
|
Receptor, erbB-2 | 5 | 2024 | 2553 | 0.500 |
Why?
|
Intestinal Neoplasms | 4 | 2013 | 314 | 0.500 |
Why?
|
Magnetic Resonance Imaging | 33 | 2023 | 36418 | 0.490 |
Why?
|
Stomach Neoplasms | 2 | 2022 | 1458 | 0.490 |
Why?
|
Peptides | 5 | 2018 | 4353 | 0.490 |
Why?
|
Endoscopes | 2 | 2007 | 169 | 0.480 |
Why?
|
Contrast Media | 11 | 2023 | 5311 | 0.480 |
Why?
|
Prostatic Neoplasms | 11 | 2022 | 11103 | 0.470 |
Why?
|
Peritoneal Neoplasms | 3 | 2022 | 710 | 0.470 |
Why?
|
Radiology | 4 | 2023 | 2114 | 0.470 |
Why?
|
Ferrosoferric Oxide | 2 | 2014 | 348 | 0.460 |
Why?
|
Antineoplastic Agents, Hormonal | 4 | 2017 | 1520 | 0.450 |
Why?
|
Osteoclasts | 2 | 2008 | 711 | 0.440 |
Why?
|
Receptors, Estrogen | 4 | 2024 | 2208 | 0.440 |
Why?
|
Silicates | 1 | 2013 | 47 | 0.440 |
Why?
|
Image Interpretation, Computer-Assisted | 4 | 2007 | 3367 | 0.440 |
Why?
|
Glass | 1 | 2013 | 115 | 0.420 |
Why?
|
Bone and Bones | 5 | 2017 | 2567 | 0.420 |
Why?
|
Neoadjuvant Therapy | 1 | 2024 | 2827 | 0.420 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2014 | 189 | 0.420 |
Why?
|
Radionuclide Imaging | 8 | 2015 | 1989 | 0.410 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2024 | 2423 | 0.410 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2014 | 445 | 0.410 |
Why?
|
Carbocyanines | 8 | 2014 | 175 | 0.410 |
Why?
|
Cell Proliferation | 7 | 2016 | 10421 | 0.410 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2016 | 566 | 0.410 |
Why?
|
Multiple Myeloma | 2 | 2022 | 5145 | 0.400 |
Why?
|
Nanoparticles | 5 | 2016 | 1959 | 0.390 |
Why?
|
Tissue Distribution | 6 | 2021 | 2262 | 0.390 |
Why?
|
Boron Compounds | 1 | 2013 | 182 | 0.390 |
Why?
|
Humans | 113 | 2024 | 761098 | 0.390 |
Why?
|
Tumor Microenvironment | 4 | 2024 | 3869 | 0.380 |
Why?
|
Peptide Hydrolases | 4 | 2009 | 616 | 0.380 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2018 | 2820 | 0.380 |
Why?
|
Green Fluorescent Proteins | 7 | 2007 | 2061 | 0.370 |
Why?
|
Indicators and Reagents | 2 | 2009 | 453 | 0.370 |
Why?
|
Colonoscopy | 4 | 2016 | 1398 | 0.370 |
Why?
|
Referral and Consultation | 1 | 2024 | 3603 | 0.370 |
Why?
|
Whole Body Imaging | 2 | 2017 | 284 | 0.360 |
Why?
|
Gliosarcoma | 3 | 2006 | 114 | 0.350 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2012 | 321 | 0.350 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2017 | 1650 | 0.350 |
Why?
|
Mice, Inbred BALB C | 11 | 2016 | 6198 | 0.350 |
Why?
|
4-Chloro-7-nitrobenzofurazan | 1 | 2009 | 21 | 0.340 |
Why?
|
Endoscopy | 4 | 2014 | 1852 | 0.340 |
Why?
|
Endopeptidases | 3 | 2004 | 766 | 0.340 |
Why?
|
Colon | 3 | 2016 | 1791 | 0.340 |
Why?
|
Molecular Biology | 3 | 2005 | 573 | 0.330 |
Why?
|
Xenograft Model Antitumor Assays | 9 | 2018 | 3591 | 0.330 |
Why?
|
Nephritis | 1 | 2010 | 147 | 0.330 |
Why?
|
Bacteriocins | 1 | 2009 | 88 | 0.330 |
Why?
|
Tomography | 3 | 2007 | 411 | 0.320 |
Why?
|
Antibodies, Monoclonal | 6 | 2016 | 9185 | 0.320 |
Why?
|
Tomography, Optical | 2 | 2007 | 129 | 0.320 |
Why?
|
Mammary Neoplasms, Experimental | 7 | 1999 | 506 | 0.320 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 1603 | 0.320 |
Why?
|
Colonic Polyps | 3 | 2016 | 553 | 0.320 |
Why?
|
Deoxyglucose | 1 | 2009 | 333 | 0.320 |
Why?
|
Autoimmune Diseases | 3 | 2010 | 2243 | 0.320 |
Why?
|
Carotid Artery, Common | 1 | 2009 | 175 | 0.310 |
Why?
|
Estradiol | 2 | 2016 | 1936 | 0.310 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2016 | 1624 | 0.310 |
Why?
|
Luminescent Proteins | 4 | 2007 | 836 | 0.310 |
Why?
|
Sensitivity and Specificity | 16 | 2022 | 14676 | 0.300 |
Why?
|
Abdominal Neoplasms | 2 | 2021 | 287 | 0.300 |
Why?
|
Androstenes | 1 | 2009 | 181 | 0.300 |
Why?
|
Diagnostic Imaging | 7 | 2008 | 3535 | 0.290 |
Why?
|
Prodrugs | 1 | 2009 | 261 | 0.290 |
Why?
|
Nanostructures | 3 | 2009 | 551 | 0.280 |
Why?
|
Aorta, Abdominal | 1 | 2010 | 625 | 0.280 |
Why?
|
Colonoscopes | 1 | 2006 | 17 | 0.280 |
Why?
|
Biopsy | 3 | 2021 | 6781 | 0.280 |
Why?
|
Microfluidics | 1 | 2012 | 651 | 0.280 |
Why?
|
Dermoscopy | 1 | 2006 | 66 | 0.260 |
Why?
|
Peroxidase | 1 | 2009 | 610 | 0.260 |
Why?
|
Gadolinium DTPA | 1 | 2009 | 823 | 0.260 |
Why?
|
Biomarkers, Pharmacological | 2 | 2017 | 161 | 0.260 |
Why?
|
Carcinoma, Lewis Lung | 1 | 2006 | 108 | 0.260 |
Why?
|
Liver Diseases | 1 | 2014 | 1300 | 0.260 |
Why?
|
HT29 Cells | 5 | 2014 | 192 | 0.250 |
Why?
|
Lung Neoplasms | 8 | 2021 | 13382 | 0.250 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2006 | 128 | 0.250 |
Why?
|
Glioblastoma | 2 | 2018 | 3481 | 0.250 |
Why?
|
Pancreatic Neoplasms | 4 | 2018 | 5366 | 0.250 |
Why?
|
Thoracoscopy | 1 | 2006 | 183 | 0.250 |
Why?
|
Indocyanine Green | 3 | 2014 | 233 | 0.250 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2014 | 876 | 0.250 |
Why?
|
Mice, Inbred C57BL | 14 | 2024 | 22129 | 0.240 |
Why?
|
Metformin | 1 | 2013 | 906 | 0.240 |
Why?
|
Adenoma | 4 | 2016 | 2159 | 0.240 |
Why?
|
Microscopy, Confocal | 6 | 2014 | 1967 | 0.240 |
Why?
|
Mesenchymal Stem Cell Transplantation | 2 | 2013 | 500 | 0.240 |
Why?
|
Lipogenesis | 2 | 2018 | 214 | 0.240 |
Why?
|
Gene Transfer Techniques | 2 | 2006 | 1201 | 0.230 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2015 | 4021 | 0.230 |
Why?
|
Female | 49 | 2024 | 392458 | 0.230 |
Why?
|
Lung | 4 | 2021 | 9979 | 0.220 |
Why?
|
Magnetic Resonance Spectroscopy | 12 | 2022 | 3770 | 0.220 |
Why?
|
Pyrazoles | 2 | 2017 | 2010 | 0.210 |
Why?
|
Carotid Artery Diseases | 1 | 2009 | 877 | 0.210 |
Why?
|
Genes, Reporter | 3 | 2018 | 1520 | 0.210 |
Why?
|
Sulfonamides | 1 | 2012 | 1977 | 0.210 |
Why?
|
Gene Expression | 5 | 2016 | 7567 | 0.200 |
Why?
|
Colitis, Ulcerative | 1 | 2014 | 1921 | 0.200 |
Why?
|
Aorta | 2 | 2009 | 2040 | 0.200 |
Why?
|
Coloring Agents | 2 | 2014 | 562 | 0.190 |
Why?
|
Pandemics | 2 | 2023 | 8663 | 0.190 |
Why?
|
Tumor Cells, Cultured | 9 | 2013 | 6123 | 0.190 |
Why?
|
Dose-Response Relationship, Drug | 8 | 2016 | 10755 | 0.190 |
Why?
|
Oxygen | 2 | 2012 | 4226 | 0.190 |
Why?
|
Protein Binding | 4 | 2018 | 9300 | 0.190 |
Why?
|
Early Diagnosis | 4 | 2012 | 1187 | 0.180 |
Why?
|
Gastrointestinal Tract | 2 | 2018 | 834 | 0.180 |
Why?
|
International Educational Exchange | 1 | 2020 | 49 | 0.180 |
Why?
|
Radiology, Interventional | 1 | 2004 | 477 | 0.180 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2010 | 1228 | 0.180 |
Why?
|
Rats | 12 | 2013 | 23713 | 0.180 |
Why?
|
Paclitaxel | 1 | 2007 | 1730 | 0.170 |
Why?
|
Fluorescence | 3 | 2008 | 754 | 0.170 |
Why?
|
Male | 41 | 2024 | 360675 | 0.170 |
Why?
|
AMP-Activated Protein Kinases | 2 | 2014 | 597 | 0.170 |
Why?
|
6-Aminonicotinamide | 2 | 1996 | 8 | 0.170 |
Why?
|
Ovarian Neoplasms | 2 | 2009 | 4853 | 0.170 |
Why?
|
Carbon Radioisotopes | 2 | 2019 | 561 | 0.170 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2017 | 1084 | 0.170 |
Why?
|
Indoles | 3 | 2014 | 1830 | 0.170 |
Why?
|
Intracranial Aneurysm | 1 | 2009 | 1286 | 0.170 |
Why?
|
Tomography, X-Ray Computed | 8 | 2021 | 20600 | 0.170 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2024 | 8529 | 0.160 |
Why?
|
Optics and Photonics | 3 | 2007 | 306 | 0.160 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2007 | 955 | 0.160 |
Why?
|
Urologic Neoplasms | 1 | 2023 | 314 | 0.160 |
Why?
|
Mice, Transgenic | 13 | 2014 | 9518 | 0.160 |
Why?
|
Cyclobutanes | 1 | 2019 | 57 | 0.160 |
Why?
|
Carboxylic Acids | 1 | 2019 | 90 | 0.160 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2015 | 5318 | 0.160 |
Why?
|
Treatment Outcome | 9 | 2019 | 64670 | 0.150 |
Why?
|
Melanoma | 1 | 2017 | 5694 | 0.150 |
Why?
|
Societies, Medical | 2 | 2020 | 3923 | 0.150 |
Why?
|
Radiology Information Systems | 1 | 2023 | 529 | 0.150 |
Why?
|
Adjuvants, Immunologic | 1 | 2023 | 988 | 0.150 |
Why?
|
Expert Testimony | 1 | 2021 | 365 | 0.150 |
Why?
|
Abdomen | 3 | 2023 | 1128 | 0.150 |
Why?
|
Software | 3 | 2007 | 4433 | 0.150 |
Why?
|
Neutrophils | 3 | 2009 | 3763 | 0.150 |
Why?
|
Cathepsin K | 2 | 2008 | 64 | 0.150 |
Why?
|
Respiratory-Gated Imaging Techniques | 1 | 2018 | 75 | 0.150 |
Why?
|
Magnetite Nanoparticles | 2 | 2013 | 316 | 0.140 |
Why?
|
Glutamate Carboxypeptidase II | 1 | 2018 | 82 | 0.140 |
Why?
|
Pilot Projects | 3 | 2022 | 8639 | 0.140 |
Why?
|
Herpesvirus 1, Human | 1 | 2023 | 739 | 0.140 |
Why?
|
Endothelium, Vascular | 1 | 2009 | 4421 | 0.140 |
Why?
|
Biotin | 1 | 2018 | 251 | 0.140 |
Why?
|
North America | 1 | 2020 | 1281 | 0.140 |
Why?
|
Imaging, Three-Dimensional | 2 | 2007 | 4060 | 0.140 |
Why?
|
Mice, Inbred Strains | 3 | 2015 | 1761 | 0.140 |
Why?
|
Neoplasm Staging | 8 | 2020 | 11118 | 0.140 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2002 | 841 | 0.140 |
Why?
|
Drug Delivery Systems | 1 | 2008 | 2223 | 0.140 |
Why?
|
Cinnamates | 1 | 2016 | 59 | 0.140 |
Why?
|
Indazoles | 2 | 2016 | 304 | 0.130 |
Why?
|
Immunosuppressive Agents | 1 | 2009 | 4189 | 0.130 |
Why?
|
Feasibility Studies | 6 | 2009 | 5249 | 0.130 |
Why?
|
Equipment Design | 4 | 2008 | 3509 | 0.130 |
Why?
|
Image Enhancement | 4 | 2009 | 2888 | 0.130 |
Why?
|
Cell Adhesion | 2 | 2015 | 3090 | 0.130 |
Why?
|
Quinazolines | 2 | 2021 | 1371 | 0.130 |
Why?
|
Phantoms, Imaging | 4 | 2014 | 2515 | 0.130 |
Why?
|
Pentose Phosphate Pathway | 1 | 1996 | 126 | 0.130 |
Why?
|
Teratogens | 1 | 1996 | 117 | 0.130 |
Why?
|
Cell Hypoxia | 2 | 2015 | 656 | 0.130 |
Why?
|
Inflammation | 8 | 2014 | 10758 | 0.130 |
Why?
|
Middle Aged | 21 | 2024 | 220835 | 0.130 |
Why?
|
Lactams, Macrocyclic | 1 | 2017 | 318 | 0.130 |
Why?
|
Osteogenesis | 1 | 2002 | 1272 | 0.120 |
Why?
|
Mesenchymal Stem Cells | 2 | 2018 | 1643 | 0.120 |
Why?
|
Ovariectomy | 2 | 2008 | 613 | 0.120 |
Why?
|
Up-Regulation | 6 | 2013 | 4111 | 0.120 |
Why?
|
Genes, APC | 3 | 2013 | 145 | 0.120 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2017 | 2787 | 0.120 |
Why?
|
Internationality | 1 | 2020 | 1000 | 0.120 |
Why?
|
Heterocyclic Compounds, 1-Ring | 1 | 2015 | 68 | 0.120 |
Why?
|
Energy Metabolism | 3 | 1995 | 2877 | 0.120 |
Why?
|
Prospective Studies | 5 | 2024 | 54419 | 0.120 |
Why?
|
Copper Radioisotopes | 1 | 2015 | 91 | 0.120 |
Why?
|
Aged | 16 | 2024 | 169266 | 0.120 |
Why?
|
Genetic Markers | 1 | 2001 | 2599 | 0.120 |
Why?
|
Combined Modality Therapy | 3 | 2024 | 8519 | 0.120 |
Why?
|
Receptors, Chemokine | 1 | 2018 | 654 | 0.120 |
Why?
|
Arthritis, Rheumatoid | 3 | 2007 | 3754 | 0.120 |
Why?
|
Pyrroles | 2 | 2012 | 1125 | 0.120 |
Why?
|
Reproducibility of Results | 6 | 2016 | 20120 | 0.120 |
Why?
|
Bone Density | 1 | 2007 | 3548 | 0.110 |
Why?
|
Cholangiocarcinoma | 1 | 2019 | 554 | 0.110 |
Why?
|
Molecular Probes | 2 | 2008 | 309 | 0.110 |
Why?
|
Bile Duct Neoplasms | 1 | 2019 | 607 | 0.110 |
Why?
|
Enzyme Activators | 1 | 2014 | 57 | 0.110 |
Why?
|
Fiber Optic Technology | 2 | 2007 | 290 | 0.110 |
Why?
|
Hindlimb | 2 | 2014 | 513 | 0.110 |
Why?
|
Brain Neoplasms | 4 | 2013 | 9025 | 0.110 |
Why?
|
Chemical Fractionation | 1 | 2013 | 61 | 0.110 |
Why?
|
Biological Transport | 1 | 2018 | 2082 | 0.110 |
Why?
|
Algorithms | 4 | 2009 | 14023 | 0.110 |
Why?
|
Public Policy | 1 | 2018 | 557 | 0.110 |
Why?
|
Antigens, Surface | 1 | 2018 | 1607 | 0.110 |
Why?
|
Denervation | 1 | 2014 | 265 | 0.110 |
Why?
|
Prognosis | 7 | 2018 | 29672 | 0.110 |
Why?
|
Postoperative Period | 1 | 2018 | 1818 | 0.110 |
Why?
|
Neoplasm, Residual | 1 | 2018 | 1008 | 0.110 |
Why?
|
Liver | 1 | 2008 | 7513 | 0.110 |
Why?
|
Signal Transduction | 7 | 2024 | 23415 | 0.110 |
Why?
|
Dimethyl Sulfoxide | 1 | 2014 | 251 | 0.100 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2018 | 491 | 0.100 |
Why?
|
Gene Expression Profiling | 3 | 2013 | 9416 | 0.100 |
Why?
|
Luminescent Measurements | 1 | 2014 | 340 | 0.100 |
Why?
|
Estrogen Receptor alpha | 1 | 2016 | 582 | 0.100 |
Why?
|
Animals, Newborn | 2 | 2008 | 2666 | 0.100 |
Why?
|
Receptors, Androgen | 1 | 2018 | 1077 | 0.100 |
Why?
|
Technetium Tc 99m Medronate | 1 | 2012 | 133 | 0.100 |
Why?
|
Papillomaviridae | 1 | 2018 | 1120 | 0.100 |
Why?
|
Immunologic Factors | 1 | 2021 | 1589 | 0.100 |
Why?
|
Cardia | 1 | 2012 | 60 | 0.100 |
Why?
|
Protein-Tyrosine Kinases | 3 | 2022 | 2426 | 0.100 |
Why?
|
Staining and Labeling | 2 | 2020 | 1081 | 0.100 |
Why?
|
Solubility | 1 | 2013 | 1085 | 0.100 |
Why?
|
Rectal Neoplasms | 1 | 2020 | 1156 | 0.100 |
Why?
|
Fibroblasts | 2 | 2014 | 4137 | 0.100 |
Why?
|
DNA, Viral | 1 | 2018 | 2195 | 0.090 |
Why?
|
Carcinoma, Pancreatic Ductal | 3 | 2014 | 1726 | 0.090 |
Why?
|
Immunohistochemistry | 5 | 2015 | 11066 | 0.090 |
Why?
|
Bone Neoplasms | 3 | 2015 | 2527 | 0.090 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2021 | 5300 | 0.090 |
Why?
|
Transfection | 3 | 2004 | 5750 | 0.090 |
Why?
|
Incidental Findings | 1 | 2016 | 698 | 0.090 |
Why?
|
Esophagoscopy | 1 | 2012 | 398 | 0.090 |
Why?
|
Esophagitis | 1 | 2012 | 165 | 0.090 |
Why?
|
Calcium Chloride | 1 | 2010 | 78 | 0.090 |
Why?
|
Orchiectomy | 1 | 2012 | 463 | 0.090 |
Why?
|
Image Processing, Computer-Assisted | 8 | 2023 | 9001 | 0.090 |
Why?
|
Length of Stay | 1 | 2024 | 6420 | 0.090 |
Why?
|
DNA Mismatch Repair | 1 | 2013 | 428 | 0.090 |
Why?
|
Oncolytic Viruses | 1 | 2014 | 344 | 0.090 |
Why?
|
Retrospective Studies | 10 | 2021 | 80673 | 0.090 |
Why?
|
Parents | 1 | 2024 | 3564 | 0.090 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2017 | 1782 | 0.090 |
Why?
|
Microvessels | 1 | 2014 | 580 | 0.090 |
Why?
|
Cyclooxygenase 2 | 1 | 2012 | 597 | 0.090 |
Why?
|
Gastrointestinal Diseases | 1 | 2018 | 1201 | 0.080 |
Why?
|
Disease-Free Survival | 3 | 2017 | 6817 | 0.080 |
Why?
|
Chondrocytes | 1 | 2015 | 792 | 0.080 |
Why?
|
Congresses as Topic | 1 | 2014 | 803 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 3 | 2010 | 8164 | 0.080 |
Why?
|
Bile Acids and Salts | 1 | 2012 | 393 | 0.080 |
Why?
|
Cells, Cultured | 5 | 2015 | 18926 | 0.080 |
Why?
|
Cryoultramicrotomy | 1 | 2008 | 16 | 0.080 |
Why?
|
Simplexvirus | 3 | 2013 | 801 | 0.080 |
Why?
|
Polymerase Chain Reaction | 1 | 2018 | 6067 | 0.080 |
Why?
|
Nanotechnology | 3 | 2013 | 713 | 0.080 |
Why?
|
Mice, Inbred C3H | 5 | 1997 | 914 | 0.080 |
Why?
|
Neoplasm Proteins | 2 | 2018 | 3594 | 0.080 |
Why?
|
Neoplasm Invasiveness | 2 | 2015 | 3591 | 0.080 |
Why?
|
Education, Medical | 1 | 2020 | 1725 | 0.080 |
Why?
|
Sex Characteristics | 1 | 2019 | 2638 | 0.080 |
Why?
|
Matrix Metalloproteinase 2 | 2 | 2020 | 459 | 0.080 |
Why?
|
Plectin | 1 | 2008 | 14 | 0.080 |
Why?
|
Genes, p53 | 2 | 2013 | 713 | 0.080 |
Why?
|
Oncolytic Virotherapy | 1 | 2014 | 515 | 0.080 |
Why?
|
Thymidine Kinase | 2 | 2023 | 286 | 0.080 |
Why?
|
Androgen Antagonists | 1 | 2017 | 1408 | 0.080 |
Why?
|
Apoptosis | 4 | 2013 | 9478 | 0.080 |
Why?
|
Cell Cycle | 2 | 2013 | 2926 | 0.080 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2009 | 180 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 5 | 2022 | 5662 | 0.080 |
Why?
|
Doxycycline | 1 | 2010 | 344 | 0.080 |
Why?
|
Annexins | 1 | 2007 | 38 | 0.080 |
Why?
|
Calcification, Physiologic | 1 | 2008 | 170 | 0.070 |
Why?
|
Somatostatin | 2 | 2022 | 447 | 0.070 |
Why?
|
Neovascularization, Pathologic | 3 | 2007 | 2635 | 0.070 |
Why?
|
Dilatation, Pathologic | 1 | 2009 | 527 | 0.070 |
Why?
|
Methotrexate | 2 | 2005 | 1717 | 0.070 |
Why?
|
Barrett Esophagus | 1 | 2012 | 492 | 0.070 |
Why?
|
Spleen | 1 | 2014 | 2290 | 0.070 |
Why?
|
Androstadienes | 1 | 2009 | 348 | 0.070 |
Why?
|
ras Proteins | 1 | 2013 | 1054 | 0.070 |
Why?
|
Photons | 2 | 2008 | 589 | 0.070 |
Why?
|
Cell Membrane Permeability | 1 | 2009 | 573 | 0.070 |
Why?
|
Miniaturization | 2 | 2005 | 153 | 0.070 |
Why?
|
Extracellular Matrix | 1 | 2015 | 1720 | 0.070 |
Why?
|
Electrons | 1 | 2008 | 265 | 0.070 |
Why?
|
Stem Cells | 2 | 2012 | 3512 | 0.070 |
Why?
|
Fibrosis | 1 | 2014 | 2051 | 0.070 |
Why?
|
Critical Pathways | 2 | 2022 | 475 | 0.070 |
Why?
|
Subtraction Technique | 1 | 2010 | 518 | 0.070 |
Why?
|
Mice, Inbred DBA | 2 | 2005 | 623 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2013 | 2864 | 0.070 |
Why?
|
Protease Inhibitors | 1 | 2010 | 752 | 0.070 |
Why?
|
Disease Progression | 6 | 2018 | 13506 | 0.070 |
Why?
|
Papillomavirus Infections | 1 | 2018 | 1615 | 0.070 |
Why?
|
Heart Defects, Congenital | 1 | 2023 | 4673 | 0.070 |
Why?
|
Homeostasis | 1 | 2017 | 3318 | 0.070 |
Why?
|
Enzyme Activation | 4 | 2006 | 3577 | 0.070 |
Why?
|
Immunoenzyme Techniques | 2 | 2006 | 1703 | 0.070 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2006 | 68 | 0.070 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2006 | 84 | 0.070 |
Why?
|
Neoplasm Metastasis | 3 | 2018 | 4908 | 0.070 |
Why?
|
Dexamethasone | 1 | 2014 | 1945 | 0.070 |
Why?
|
Cell Survival | 4 | 2013 | 5776 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3776 | 0.070 |
Why?
|
Nonmuscle Myosin Type IIA | 1 | 2006 | 28 | 0.070 |
Why?
|
Peritoneum | 1 | 2007 | 225 | 0.070 |
Why?
|
Computer Systems | 1 | 2007 | 470 | 0.060 |
Why?
|
Antirheumatic Agents | 2 | 2007 | 1366 | 0.060 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2010 | 677 | 0.060 |
Why?
|
Phosphorus | 3 | 1996 | 332 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2008 | 636 | 0.060 |
Why?
|
Epigenesis, Genetic | 1 | 2019 | 3790 | 0.060 |
Why?
|
Leukocytes | 1 | 2014 | 2024 | 0.060 |
Why?
|
I-kappa B Kinase | 1 | 2007 | 249 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2019 | 9278 | 0.060 |
Why?
|
Capillary Permeability | 2 | 2006 | 773 | 0.060 |
Why?
|
Thiazolidinediones | 1 | 2008 | 460 | 0.060 |
Why?
|
Carboplatin | 1 | 2008 | 793 | 0.060 |
Why?
|
Bone Development | 1 | 2008 | 470 | 0.060 |
Why?
|
Glucose | 3 | 2013 | 4341 | 0.060 |
Why?
|
Mice, Inbred NOD | 3 | 2023 | 1822 | 0.060 |
Why?
|
Equipment Failure Analysis | 1 | 2007 | 846 | 0.060 |
Why?
|
Mice, Knockout | 7 | 2010 | 14393 | 0.060 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2006 | 212 | 0.060 |
Why?
|
Annexin A5 | 1 | 2005 | 103 | 0.060 |
Why?
|
Carbolines | 1 | 2007 | 295 | 0.060 |
Why?
|
Bone Resorption | 1 | 2008 | 723 | 0.060 |
Why?
|
Ferric Compounds | 2 | 2003 | 378 | 0.060 |
Why?
|
Niacinamide | 1 | 2007 | 413 | 0.060 |
Why?
|
Time Factors | 5 | 2013 | 39953 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3689 | 0.060 |
Why?
|
Osteoarthritis, Knee | 1 | 2015 | 1235 | 0.060 |
Why?
|
Fracture Healing | 1 | 2007 | 445 | 0.060 |
Why?
|
Pancreatic Ducts | 1 | 2006 | 329 | 0.060 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2010 | 1745 | 0.060 |
Why?
|
Adult | 11 | 2024 | 221083 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2019 | 58946 | 0.060 |
Why?
|
Cerebral Angiography | 1 | 2009 | 1281 | 0.060 |
Why?
|
Monte Carlo Method | 1 | 2009 | 1257 | 0.060 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2007 | 620 | 0.060 |
Why?
|
Motion | 2 | 2018 | 779 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2013 | 11732 | 0.050 |
Why?
|
Histocytochemistry | 1 | 2004 | 697 | 0.050 |
Why?
|
Burns | 1 | 2014 | 1875 | 0.050 |
Why?
|
Cell Count | 1 | 2007 | 1831 | 0.050 |
Why?
|
Cathepsin D | 2 | 2000 | 59 | 0.050 |
Why?
|
Infant, Newborn | 2 | 2021 | 26187 | 0.050 |
Why?
|
Bacteriophages | 1 | 2006 | 378 | 0.050 |
Why?
|
Rabbits | 1 | 2009 | 4749 | 0.050 |
Why?
|
RNA, Messenger | 4 | 2008 | 12743 | 0.050 |
Why?
|
Oxides | 1 | 2004 | 401 | 0.050 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 696 | 0.050 |
Why?
|
CpG Islands | 1 | 2007 | 1190 | 0.050 |
Why?
|
Receptors, IgG | 2 | 2006 | 558 | 0.050 |
Why?
|
Dextrans | 1 | 2004 | 574 | 0.050 |
Why?
|
Enzyme Inhibitors | 2 | 2018 | 3700 | 0.050 |
Why?
|
Sirolimus | 1 | 2010 | 1540 | 0.050 |
Why?
|
Esophagus | 1 | 2008 | 1033 | 0.050 |
Why?
|
Capillaries | 1 | 2006 | 755 | 0.050 |
Why?
|
Lactate Dehydrogenases | 1 | 2022 | 26 | 0.050 |
Why?
|
Prostate-Specific Antigen | 3 | 2019 | 2465 | 0.050 |
Why?
|
Luciferases | 1 | 2004 | 711 | 0.050 |
Why?
|
Glioma | 2 | 2007 | 3452 | 0.050 |
Why?
|
Peptides, Cyclic | 1 | 2004 | 392 | 0.050 |
Why?
|
Neurofibromatosis 2 | 1 | 2006 | 383 | 0.050 |
Why?
|
Developing Countries | 1 | 2014 | 2862 | 0.050 |
Why?
|
Femur | 1 | 2008 | 1308 | 0.050 |
Why?
|
Arthritis | 1 | 2007 | 681 | 0.050 |
Why?
|
Cell Line | 4 | 2009 | 15542 | 0.050 |
Why?
|
Hexokinase | 1 | 2022 | 124 | 0.050 |
Why?
|
Glucose Transporter Type 1 | 1 | 2022 | 185 | 0.050 |
Why?
|
Macrophage Activation | 1 | 2005 | 552 | 0.050 |
Why?
|
Microradiography | 1 | 2001 | 13 | 0.050 |
Why?
|
Marmota | 1 | 2021 | 12 | 0.050 |
Why?
|
Antibodies | 1 | 2009 | 2415 | 0.050 |
Why?
|
Spectrum Analysis | 2 | 2020 | 449 | 0.050 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2023 | 296 | 0.050 |
Why?
|
Autoantigens | 1 | 2006 | 887 | 0.050 |
Why?
|
Receptors, Peptide | 1 | 2023 | 279 | 0.050 |
Why?
|
Cadherins | 1 | 2006 | 902 | 0.050 |
Why?
|
Lactates | 1 | 2022 | 401 | 0.050 |
Why?
|
Pyruvic Acid | 1 | 2022 | 203 | 0.050 |
Why?
|
Light | 1 | 2007 | 1351 | 0.050 |
Why?
|
Models, Biological | 3 | 2013 | 9455 | 0.050 |
Why?
|
Organ Specificity | 1 | 2006 | 1963 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2009 | 6224 | 0.050 |
Why?
|
Immunoglobulin M | 1 | 2006 | 1527 | 0.050 |
Why?
|
Neurilemmoma | 1 | 2006 | 523 | 0.040 |
Why?
|
Mice, Mutant Strains | 1 | 2003 | 1750 | 0.040 |
Why?
|
Cathepsin H | 1 | 1999 | 10 | 0.040 |
Why?
|
Electromagnetic Phenomena | 1 | 2021 | 160 | 0.040 |
Why?
|
Child | 3 | 2024 | 80134 | 0.040 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2005 | 3416 | 0.040 |
Why?
|
Genomics | 1 | 2015 | 5828 | 0.040 |
Why?
|
Urinary Bladder | 1 | 2005 | 1152 | 0.040 |
Why?
|
Histone Deacetylase 2 | 1 | 2019 | 72 | 0.040 |
Why?
|
Cell Differentiation | 2 | 2008 | 11505 | 0.040 |
Why?
|
Collagen | 2 | 2005 | 2635 | 0.040 |
Why?
|
Angiogenesis Inhibitors | 1 | 2009 | 2047 | 0.040 |
Why?
|
Brain | 3 | 2019 | 27097 | 0.040 |
Why?
|
DNA | 1 | 2013 | 7189 | 0.040 |
Why?
|
Reperfusion Injury | 1 | 2006 | 1026 | 0.040 |
Why?
|
Reference Values | 1 | 2006 | 4922 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2006 | 2914 | 0.040 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2013 | 2057 | 0.040 |
Why?
|
RNA Interference | 1 | 2007 | 2816 | 0.040 |
Why?
|
Complement System Proteins | 1 | 2002 | 737 | 0.040 |
Why?
|
Histone Deacetylase 1 | 1 | 2019 | 133 | 0.040 |
Why?
|
Organizational Objectives | 1 | 2020 | 426 | 0.040 |
Why?
|
Particle Size | 3 | 2013 | 1649 | 0.040 |
Why?
|
Pancreas | 1 | 2005 | 1685 | 0.040 |
Why?
|
Receptors, Transferrin | 1 | 2000 | 291 | 0.040 |
Why?
|
Adamantane | 1 | 2019 | 148 | 0.040 |
Why?
|
Genetic Techniques | 1 | 2001 | 428 | 0.040 |
Why?
|
RNA, Small Interfering | 1 | 2007 | 3409 | 0.040 |
Why?
|
Killer Cells, Natural | 1 | 2007 | 2194 | 0.040 |
Why?
|
Sarcoma | 1 | 2009 | 1800 | 0.040 |
Why?
|
Standard of Care | 1 | 2022 | 550 | 0.040 |
Why?
|
Islets of Langerhans | 1 | 2004 | 1341 | 0.040 |
Why?
|
Folic Acid | 1 | 2005 | 1323 | 0.040 |
Why?
|
Cell Movement | 2 | 2008 | 5195 | 0.040 |
Why?
|
Arteriosclerosis | 1 | 2002 | 1056 | 0.040 |
Why?
|
Tuberous Sclerosis | 1 | 2005 | 1031 | 0.040 |
Why?
|
Infrared Rays | 1 | 1999 | 247 | 0.040 |
Why?
|
Interleukin-1beta | 2 | 2015 | 1002 | 0.040 |
Why?
|
Kallikreins | 1 | 2019 | 220 | 0.040 |
Why?
|
Computational Biology | 2 | 2009 | 3499 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2022 | 2455 | 0.040 |
Why?
|
Oligopeptides | 2 | 2000 | 1178 | 0.040 |
Why?
|
Central Nervous System Neoplasms | 1 | 2006 | 915 | 0.040 |
Why?
|
Anilides | 1 | 2020 | 411 | 0.040 |
Why?
|
Phosphocreatine | 2 | 1995 | 261 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2014 | 5427 | 0.030 |
Why?
|
Cysteine Endopeptidases | 1 | 1999 | 551 | 0.030 |
Why?
|
Patient Care | 1 | 2022 | 622 | 0.030 |
Why?
|
Phosphorylcholine | 2 | 1994 | 153 | 0.030 |
Why?
|
Methylthioinosine | 1 | 1996 | 4 | 0.030 |
Why?
|
Phosphonoacetic Acid | 1 | 1996 | 54 | 0.030 |
Why?
|
Seizures | 1 | 2009 | 2965 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2008 | 3666 | 0.030 |
Why?
|
Organophosphorus Compounds | 1 | 1997 | 207 | 0.030 |
Why?
|
Lactams | 1 | 2017 | 156 | 0.030 |
Why?
|
Hydroxamic Acids | 1 | 2019 | 479 | 0.030 |
Why?
|
Hormones | 1 | 2020 | 869 | 0.030 |
Why?
|
Lymph Nodes | 2 | 2010 | 3461 | 0.030 |
Why?
|
Iron | 1 | 2004 | 1790 | 0.030 |
Why?
|
Dendritic Cells | 1 | 2007 | 2726 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1837 | 0.030 |
Why?
|
Phosphatidylcholines | 1 | 1997 | 404 | 0.030 |
Why?
|
Pelvis | 1 | 2020 | 734 | 0.030 |
Why?
|
Mutation | 5 | 2013 | 30006 | 0.030 |
Why?
|
Hypoglycemic Agents | 1 | 2008 | 3086 | 0.030 |
Why?
|
Isotope Labeling | 1 | 2017 | 393 | 0.030 |
Why?
|
Choline | 1 | 1997 | 515 | 0.030 |
Why?
|
Deoxyuracil Nucleotides | 1 | 1995 | 13 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2005 | 2802 | 0.030 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 1994 | 880 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2005 | 2802 | 0.030 |
Why?
|
Technology, Radiologic | 1 | 1995 | 160 | 0.030 |
Why?
|
Proteomics | 1 | 2009 | 3836 | 0.030 |
Why?
|
Cyclophosphamide | 2 | 2005 | 2219 | 0.030 |
Why?
|
Fractures, Bone | 1 | 2007 | 2045 | 0.030 |
Why?
|
Peptide Library | 2 | 2008 | 347 | 0.030 |
Why?
|
Virus Replication | 1 | 2023 | 2426 | 0.030 |
Why?
|
Genetic Engineering | 2 | 2013 | 929 | 0.030 |
Why?
|
Biophysical Phenomena | 1 | 1995 | 321 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 2 | 2009 | 546 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2017 | 627 | 0.030 |
Why?
|
Quinolines | 2 | 2013 | 764 | 0.030 |
Why?
|
Melanoma, Amelanotic | 1 | 2014 | 19 | 0.030 |
Why?
|
Phosphates | 2 | 1995 | 763 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2020 | 5870 | 0.030 |
Why?
|
Intestinal Mucosa | 1 | 2005 | 3030 | 0.030 |
Why?
|
Phospholipids | 2 | 1995 | 784 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6482 | 0.030 |
Why?
|
Biophysics | 1 | 1995 | 379 | 0.030 |
Why?
|
Down-Regulation | 2 | 2014 | 2915 | 0.030 |
Why?
|
MAP Kinase Signaling System | 2 | 2013 | 1480 | 0.030 |
Why?
|
Joints | 2 | 2007 | 322 | 0.030 |
Why?
|
Membrane Lipids | 1 | 1995 | 251 | 0.030 |
Why?
|
Aspartic Acid | 1 | 1996 | 574 | 0.030 |
Why?
|
Nepal | 1 | 2014 | 300 | 0.030 |
Why?
|
Esters | 1 | 1994 | 210 | 0.030 |
Why?
|
Aminopyridines | 1 | 2017 | 573 | 0.030 |
Why?
|
Vero Cells | 1 | 2014 | 482 | 0.030 |
Why?
|
Serum | 1 | 2014 | 208 | 0.030 |
Why?
|
MutS Homolog 2 Protein | 1 | 2013 | 197 | 0.030 |
Why?
|
Paralysis | 1 | 2014 | 250 | 0.030 |
Why?
|
Ganciclovir | 1 | 2013 | 253 | 0.030 |
Why?
|
Synovial Fluid | 2 | 2005 | 393 | 0.030 |
Why?
|
Menisci, Tibial | 1 | 2015 | 267 | 0.030 |
Why?
|
Substrate Specificity | 3 | 2002 | 1768 | 0.030 |
Why?
|
Tumor Burden | 1 | 2018 | 1892 | 0.030 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2013 | 193 | 0.030 |
Why?
|
Point-of-Care Systems | 1 | 2021 | 1213 | 0.030 |
Why?
|
Microscopy, Atomic Force | 1 | 2013 | 252 | 0.030 |
Why?
|
Tamoxifen | 1 | 2016 | 965 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 2017 | 1129 | 0.020 |
Why?
|
Organic Chemicals | 1 | 2013 | 210 | 0.020 |
Why?
|
Nucleotides | 1 | 1994 | 452 | 0.020 |
Why?
|
Glycolysis | 1 | 1996 | 836 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2005 | 4933 | 0.020 |
Why?
|
Bone Morphogenetic Protein 4 | 1 | 2012 | 163 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2009 | 714 | 0.020 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 1995 | 617 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2007 | 15308 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39121 | 0.020 |
Why?
|
Ankle | 1 | 2014 | 350 | 0.020 |
Why?
|
Metaplasia | 1 | 2012 | 324 | 0.020 |
Why?
|
Integrases | 1 | 2013 | 518 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2017 | 2328 | 0.020 |
Why?
|
Prostate | 1 | 2019 | 1772 | 0.020 |
Why?
|
Adolescent | 4 | 2023 | 88271 | 0.020 |
Why?
|
Salvage Therapy | 1 | 2017 | 1264 | 0.020 |
Why?
|
Young Adult | 4 | 2019 | 59199 | 0.020 |
Why?
|
Polylysine | 2 | 2000 | 131 | 0.020 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2016 | 801 | 0.020 |
Why?
|
Homeodomain Proteins | 2 | 2012 | 2413 | 0.020 |
Why?
|
Tissue Donors | 1 | 2019 | 2334 | 0.020 |
Why?
|
Sex Distribution | 1 | 2014 | 2278 | 0.020 |
Why?
|
ran GTP-Binding Protein | 1 | 2009 | 53 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2013 | 719 | 0.020 |
Why?
|
Viral Load | 1 | 2018 | 3328 | 0.020 |
Why?
|
Microspheres | 2 | 2002 | 783 | 0.020 |
Why?
|
Luminescence | 1 | 2009 | 108 | 0.020 |
Why?
|
Receptor, Notch1 | 1 | 2012 | 497 | 0.020 |
Why?
|
Prostatectomy | 1 | 2017 | 1825 | 0.020 |
Why?
|
Age Distribution | 1 | 2014 | 2873 | 0.020 |
Why?
|
Ear | 1 | 2009 | 172 | 0.020 |
Why?
|
Uteroglobin | 1 | 2008 | 56 | 0.020 |
Why?
|
Cell Division | 1 | 1996 | 4451 | 0.020 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2009 | 183 | 0.020 |
Why?
|
Mucins | 1 | 2012 | 569 | 0.020 |
Why?
|
Genotype | 2 | 2013 | 12983 | 0.020 |
Why?
|
Bromodeoxyuridine | 1 | 2008 | 310 | 0.020 |
Why?
|
Aging | 1 | 2007 | 8701 | 0.020 |
Why?
|
Pyridines | 1 | 2020 | 2872 | 0.020 |
Why?
|
Employment | 1 | 2014 | 1114 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2013 | 1125 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2013 | 1240 | 0.020 |
Why?
|
Esophageal Diseases | 1 | 2008 | 168 | 0.020 |
Why?
|
Lactic Acid | 1 | 2013 | 1139 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2013 | 1743 | 0.020 |
Why?
|
Emotions | 1 | 2019 | 2740 | 0.020 |
Why?
|
Imidazoles | 1 | 2013 | 1173 | 0.020 |
Why?
|
Educational Status | 1 | 2014 | 2510 | 0.020 |
Why?
|
Patient Selection | 1 | 2019 | 4245 | 0.020 |
Why?
|
Urban Population | 1 | 2014 | 2035 | 0.020 |
Why?
|
Muscle Proteins | 1 | 2012 | 1149 | 0.020 |
Why?
|
Mesoderm | 1 | 2009 | 673 | 0.020 |
Why?
|
Treatment Failure | 1 | 2012 | 2643 | 0.020 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2006 | 89 | 0.020 |
Why?
|
Erythrocyte Volume | 1 | 2005 | 28 | 0.020 |
Why?
|
Neural Cell Adhesion Molecules | 1 | 2006 | 122 | 0.020 |
Why?
|
Adherens Junctions | 1 | 2006 | 90 | 0.020 |
Why?
|
Radiation Dosage | 1 | 1994 | 1966 | 0.020 |
Why?
|
Genes, ras | 1 | 2008 | 654 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2013 | 2706 | 0.020 |
Why?
|
PPAR gamma | 1 | 2008 | 483 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2009 | 1334 | 0.020 |
Why?
|
DNA, Recombinant | 1 | 2006 | 455 | 0.020 |
Why?
|
Folate Receptors, GPI-Anchored | 1 | 2005 | 23 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2014 | 2307 | 0.020 |
Why?
|
Random Allocation | 1 | 2009 | 2393 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2017 | 4510 | 0.010 |
Why?
|
Interleukin-12 | 1 | 2007 | 578 | 0.010 |
Why?
|
Phenotype | 2 | 2017 | 16572 | 0.010 |
Why?
|
Lentivirus | 1 | 2007 | 507 | 0.010 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2008 | 899 | 0.010 |
Why?
|
Oligonucleotides | 1 | 2007 | 563 | 0.010 |
Why?
|
Plasmids | 1 | 2009 | 2261 | 0.010 |
Why?
|
Binding Sites | 1 | 2013 | 5993 | 0.010 |
Why?
|
Histamine | 1 | 2006 | 499 | 0.010 |
Why?
|
Antigen-Antibody Complex | 1 | 2006 | 509 | 0.010 |
Why?
|
Rural Population | 1 | 2014 | 2277 | 0.010 |
Why?
|
Epithelium | 1 | 2008 | 1603 | 0.010 |
Why?
|
Jejunum | 1 | 2006 | 472 | 0.010 |
Why?
|
Blood Proteins | 1 | 2009 | 1172 | 0.010 |
Why?
|
Blood Vessels | 1 | 2009 | 1111 | 0.010 |
Why?
|
Cohort Studies | 2 | 2020 | 41486 | 0.010 |
Why?
|
Computer Security | 1 | 2005 | 260 | 0.010 |
Why?
|
Hospitalization | 1 | 2023 | 10712 | 0.010 |
Why?
|
Radionuclide Angiography | 1 | 2002 | 23 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2000 | 4565 | 0.010 |
Why?
|
Gated Blood-Pool Imaging | 1 | 2002 | 44 | 0.010 |
Why?
|
Fibrosarcoma | 2 | 1996 | 308 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 2003 | 525 | 0.010 |
Why?
|
Gamma Cameras | 1 | 2002 | 35 | 0.010 |
Why?
|
Transduction, Genetic | 1 | 2005 | 900 | 0.010 |
Why?
|
Rats, Inbred F344 | 1 | 2003 | 826 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9648 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18385 | 0.010 |
Why?
|
Magnetics | 1 | 2005 | 598 | 0.010 |
Why?
|
Transgenes | 1 | 2005 | 1008 | 0.010 |
Why?
|
Health Expenditures | 1 | 2014 | 2363 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2004 | 925 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4813 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2010 | 2913 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2012 | 3210 | 0.010 |
Why?
|
Receptor, Anaphylatoxin C5a | 1 | 2002 | 87 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2009 | 2189 | 0.010 |
Why?
|
Chemistry Techniques, Analytical | 1 | 2001 | 48 | 0.010 |
Why?
|
Transillumination | 1 | 2001 | 20 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10083 | 0.010 |
Why?
|
Receptors, Complement | 1 | 2002 | 254 | 0.010 |
Why?
|
Genes, Tumor Suppressor | 1 | 2005 | 1057 | 0.010 |
Why?
|
Homozygote | 1 | 2006 | 1775 | 0.010 |
Why?
|
Serotonin | 1 | 2006 | 1043 | 0.010 |
Why?
|
Cysts | 1 | 2006 | 680 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2014 | 3197 | 0.010 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2002 | 517 | 0.010 |
Why?
|
Muscle, Skeletal | 2 | 2006 | 4947 | 0.010 |
Why?
|
Exons | 1 | 2006 | 2380 | 0.010 |
Why?
|
Kinetics | 2 | 1999 | 6312 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2005 | 1696 | 0.010 |
Why?
|
Logistic Models | 1 | 2014 | 13254 | 0.010 |
Why?
|
Blotting, Western | 1 | 2007 | 5033 | 0.010 |
Why?
|
Macrophages | 2 | 2005 | 5754 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2870 | 0.010 |
Why?
|
Microcirculation | 1 | 2004 | 1280 | 0.010 |
Why?
|
Cell Membrane | 1 | 2009 | 3665 | 0.010 |
Why?
|
Nitric Oxide Synthase | 1 | 2002 | 908 | 0.010 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 1999 | 222 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2006 | 3779 | 0.010 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2002 | 705 | 0.010 |
Why?
|
Cross-Linking Reagents | 1 | 2002 | 684 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2007 | 3155 | 0.010 |
Why?
|
Magnetic Resonance Angiography | 1 | 2005 | 1432 | 0.010 |
Why?
|
Administration, Oral | 1 | 2007 | 4014 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2006 | 1662 | 0.010 |
Why?
|
Mast Cells | 1 | 2006 | 1392 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2008 | 6305 | 0.010 |
Why?
|
Arginine | 1 | 2002 | 921 | 0.010 |
Why?
|
Gene Deletion | 1 | 2006 | 2656 | 0.010 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2003 | 732 | 0.010 |
Why?
|
NF-kappa B | 1 | 2007 | 2475 | 0.010 |
Why?
|
Polyethylenes | 1 | 2000 | 290 | 0.010 |
Why?
|
Autoimmunity | 1 | 2006 | 1354 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2007 | 1812 | 0.010 |
Why?
|
Prevalence | 1 | 2014 | 15717 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2009 | 3568 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 12975 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2005 | 2200 | 0.010 |
Why?
|
Ischemia | 1 | 2006 | 1889 | 0.010 |
Why?
|
Apolipoproteins E | 1 | 2002 | 1443 | 0.010 |
Why?
|
Immune System | 1 | 2002 | 792 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2006 | 3388 | 0.010 |
Why?
|
Models, Animal | 1 | 2002 | 2114 | 0.010 |
Why?
|
Thyroid Gland | 1 | 2002 | 1170 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2009 | 7574 | 0.010 |
Why?
|
Phosphorus Isotopes | 1 | 1995 | 124 | 0.010 |
Why?
|
Carbon Isotopes | 1 | 1996 | 458 | 0.010 |
Why?
|
X-Rays | 1 | 1996 | 308 | 0.010 |
Why?
|
United States | 1 | 2023 | 72337 | 0.010 |
Why?
|
Phosphorylation | 1 | 2005 | 8303 | 0.010 |
Why?
|
Polyethylene Glycols | 1 | 1999 | 1187 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2006 | 3044 | 0.010 |
Why?
|
Lysosomes | 1 | 1999 | 920 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2014 | 26068 | 0.010 |
Why?
|
Leukemia, Experimental | 1 | 1993 | 225 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2005 | 4538 | 0.010 |
Why?
|
Internet | 1 | 2005 | 3094 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2005 | 3550 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2004 | 13404 | 0.010 |
Why?
|
Infant | 1 | 2014 | 36164 | 0.010 |
Why?
|
Transcription Factors | 1 | 2012 | 12096 | 0.010 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 1996 | 549 | 0.010 |
Why?
|
Child, Preschool | 1 | 2014 | 42217 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2004 | 17598 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2000 | 3725 | 0.010 |
Why?
|
Antigens, CD | 1 | 2002 | 4008 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 1999 | 2381 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2005 | 4251 | 0.000 |
Why?
|